Eye on ASCO Day 3 – Pricey combos cause panic
asco, cancer, Haematology, pricing, respiratory
0 Comment
But is it pharma’s fault?
ASCO-pp
Eye on ASCO Day 2 – Precision medicine takes centre stage
asco, Bristol-Myers Squibb, cancer, Oncology, precision medicine, Roche
0 Comment
Data from one of the largest cancer genomics studies ever conducted.
